These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 13824088)
1. The use of protein anabolizers. FOSS GL Br J Clin Pract; 1959 Aug; 13():541-5. PubMed ID: 13824088 [No Abstract] [Full Text] [Related]
2. Treatment of far-advanced inoperable carcinoma of the breast with estrogens and androgens. TAYLOR SG; SLAUGHTER D; PRESTON FW J Clin Endocrinol Metab; 1948 Jul; 8(7):585. PubMed ID: 18869607 [No Abstract] [Full Text] [Related]
3. Treatment of the menopause syndrome; advantages of combining oral androgens with estrogens. GLASS SJ Ann West Med Surg; 1949 May; 3(5):186. PubMed ID: 18145044 [No Abstract] [Full Text] [Related]
4. The use of estrogens and androgens in advanced mammary cancer; clinical and laboratory study of 105 female patients. ADAIR FE; MELLORS RC J Am Med Assoc; 1949 Aug; 140(15):1193-1200. PubMed ID: 18136181 [No Abstract] [Full Text] [Related]
5. Treatment of postmenopausal osteoporosis with oestrogens and androgens. HERNBERG CA Acta Endocrinol (Copenh); 1960 May; 34():51-9. PubMed ID: 14401286 [No Abstract] [Full Text] [Related]
6. [Hormone therapy and breast cancer]. RAVAULT PP; MORNEX R J Med Lyon; 1962 Jan; 43():139-48. PubMed ID: 14490624 [No Abstract] [Full Text] [Related]
8. [The importance of tissue culture for hormone therapy in breast carcinoma]. KELLNER G; TURCIC G Klin Med Osterr Z Wiss Prakt Med; 1962 Feb; 17():83-9. PubMed ID: 14454991 [No Abstract] [Full Text] [Related]
9. On the influence of androgen and estrogen administration on chemically induced albino rat sarcoma. SETALA K Ann Med Exp Biol Fenn; 1947; 25(1):5-23. PubMed ID: 18920724 [No Abstract] [Full Text] [Related]
10. [Principles and indications for therapy with protein-anabolic steroids]. KRUESKEMPER HL Internist (Berl); 1962 Jun; 3():323-32. PubMed ID: 14459903 [No Abstract] [Full Text] [Related]
11. [Contribution to the treatment of extragenital climacteric disorders with a combination of estrogens and androgens]. VRANA M Cesk Gynekol; 1960 Dec; 25():768-70. PubMed ID: 13782215 [No Abstract] [Full Text] [Related]
12. [Clinico-experimental investigations of 1-methylandrostenolone with a protein-anabolic effect]. BREUER H; KRUESKEMPER HL; BARTSCH W Dtsch Med Wochenschr; 1962 Jun; 87():1349-53. PubMed ID: 13872948 [No Abstract] [Full Text] [Related]
13. [Androstanolone-base in therapeutics]. BUSSIERE Rev Int Serv Sante Armees; 1959; 32():487-90. PubMed ID: 13806439 [No Abstract] [Full Text] [Related]
14. [Absence of water-salt retention following the injection of a delayed-action estrogen-progesterone-androgen combination]. LINQUETTE M; FOSSATI P Lille Med; 1962; 7():557-60. PubMed ID: 14465640 [No Abstract] [Full Text] [Related]
15. [Hormonal treatment of cancer of the breast]. REMY EF Dia Med; 1961 Oct; 33():2322-8. PubMed ID: 14491433 [No Abstract] [Full Text] [Related]
16. [Combined use of sex steroid hormones in the climacteric syndrome in patients with hypertension and arteriosclerosis]. VIKHLIAEVA EM; KAWMYKOVA VI Klin Med (Mosk); 1962 Mar; 40():105-12. PubMed ID: 13925912 [No Abstract] [Full Text] [Related]
17. [Attempted correction with androstanolone of disorders of protein metabolism in cirrhotics]. TROCME P; ROY J Sem Hop Ther Paris; 1962 Jan; 38():22-5. PubMed ID: 13922546 [No Abstract] [Full Text] [Related]
18. [Protein deficiency states in surgery and their therapy]. JENKNER FL Med Welt; 1960 Apr; 16():838-40. PubMed ID: 13853127 [No Abstract] [Full Text] [Related]
19. The use of androgens in men. HELLER CG; MADDOCK WO Bull N Y Acad Med; 1948 Mar; 24(3):179-94. PubMed ID: 18906635 [No Abstract] [Full Text] [Related]